Search Results

• • 4 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Trends in transcatheter and surgical aortic valve replacement in the United States, 2008-2018.

  Authors:Katherine AA Clark, Fouad Chouairi, Bradley Kay, Samuel W Reinhardt, P Elliott Miller, Michael Fuery, et al.From:American Heart Journal (Vol. 243) Peer-Reviewed

  Jan. 2022281 words Brief article

   Abstract Only

• Comparison of Transcatheter and Open Mitral Valve Repair Among Patients With Mitral Regurgitation.

  Authors:Bradley Kay, Fouad Chouairi, Katherine A.A. Clark, Samuel W. Reinhardt, Michael Fuery, Avirup Guha, et al.From:Mayo Clinic Proceedings (Vol. 96, Issue 6) Peer-Reviewed

  June 20213,112 words Report 1610LAbstract In 2013, the Food and Drug Administration approved the first transcatheter mitral valve repair (TMVr) device for degenerative mitral regurgitation for patients at prohibitive surgical risk. To better...

• Personalizing the decision of dabigatran versus warfarin in atrial fibrillation: A secondary analysis of the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) trial.

  Authors:Samuel W. Reinhardt, Nihar R. Desai, Yuanyuan Tang, Philip G. Jones, Jeremy Ader, and John A. SpertusFrom:PLoS ONE (Vol. 16, Issue 8) Peer-Reviewed

  Aug. 19, 20215,992 words Report 1610LBackground The RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial demonstrated that higher-risk patients with atrial fibrillation had lower rates of stroke or systemic embolism and a similar rate...

• Noninvasive Cardiac Testing vs Clinical Evaluation Alone in Acute Chest Pain: A Secondary Analysis of the ROMICAT-II Randomized Clinical Trial

  Authors:Samuel W. Reinhardt, Chien-Jung Lin, and Eric NovakFrom:JAMA Internal Medicine (Vol. 178, Issue 2) Peer-Reviewed

  Feb. 2018 Article

   Citation Only